Core Insights - The latest episode of The Bell2Bell Podcast features Moishe Gubin, Chairman and CEO of Strawberry Fields REIT Inc., focusing on the company's operations in the skilled nursing and healthcare property sectors [2][3]. Company Overview - Strawberry Fields REIT is a self-administered real estate investment trust that owns, acquires, and leases skilled nursing and healthcare-related properties, with a portfolio of 142 facilities and over 15,500 beds across 10 states [7]. Business Model - The company operates on a triple-net lease structure with 10-year leases and two five-year renewal options, with 93% of its assets being skilled nursing facilities [3][4]. - The leadership team has a strong operational background in nursing homes, allowing for strategic tenant evaluations and operational stability [4]. Financial Performance - Strawberry Fields REIT has maintained a consistent financial discipline, having collected 100% of its rents over the past 10 years without writing off any bad loans [5]. - The company distributes 45% to 50% of its earnings, reinvesting the remainder to grow asset value at an annual rate of 11% [5].

Core Viewpoint - Investors in the Banks - Foreign sector should consider Bancolombia (CIB) as a potentially undervalued stock compared to ICICI Bank Limited (IBN) [1] Group 1: Company Rankings and Outlook - Bancolombia has a Zacks Rank of 1 (Strong Buy), while ICICI Bank has a Zacks Rank of 3 (Hold) [3] - CIB has likely experienced a stronger improvement in its earnings outlook compared to IBN [3] Group 2: Valuation Metrics - CIB has a forward P/E ratio of 7.51, significantly lower than IBN's forward P/E of 20.13 [5] - CIB's PEG ratio is 1.06, while IBN's PEG ratio is 2.02, indicating CIB's better valuation relative to its expected earnings growth [5] - CIB's P/B ratio is 2.38, compared to IBN's P/B of 2.83, further supporting CIB's superior valuation metrics [6] Group 3: Value Grades - CIB has earned a Value grade of A, while IBN has received a Value grade of D, highlighting CIB's stronger position in terms of value investing [6]

Core Insights - Strawberry Fields REIT Inc. has appointed IBN to lead its corporate communications efforts, aiming to enhance its visibility in the market [1][4][5] Company Overview - Strawberry Fields REIT was spun out in 2015 with an initial portfolio of 33 properties in Indiana and Illinois, and has since expanded to own and lease healthcare facilities across 10 states [2] - The REIT currently owns and holds long-term leasehold interests in 142 healthcare facilities, totaling over 15,500 licensed beds, which include 130 skilled nursing facilities, 10 assisted living facilities, and 2 long-term acute care hospitals [3][6] Strategic Focus - The company's strategy emphasizes collaboration with regional operators and consultants, targeting markets with favorable demographic trends and regulatory conditions that support long-term demand for healthcare services [2] Communication Strategy - IBN will utilize its extensive distribution network, which includes over 5,000 syndication outlets and various media channels, to increase awareness of Strawberry Fields REIT among investors and the public [4][5]

Core Insights - Oncotelic Therapeutics Inc. has selected IBN to lead its corporate communications efforts, aiming to enhance awareness and engagement with investors and the public [1][5][6] Company Overview - Oncotelic is a clinical-stage biopharmaceutical company focused on developing RNA-based immunotherapy and targeted therapeutics for cancer and underserved diseases, particularly in difficult-to-treat and rare conditions [2][7] - The company’s lead candidate, OT-101, is currently in a Phase 3 trial for pancreatic ductal adenocarcinoma and has been evaluated for gliomas and metastatic tumors in combination with IL-2 and checkpoint inhibitors [2] Leadership and Innovation - Dr. Vuong Trieu, the Chairman and CEO, has a strong background in the industry, having filed over 500 patent applications with 75 issued to date, and co-invented Abraxane®, which was sold for $2.9 billion [3][8] - Oncotelic holds a 45% stake in GMP Biotechnology Limited, enabling support for regulatory filings for up to 20 drug candidates, and utilizes its proprietary AI platform, PDAOAI, for regulatory workflows and scientific data analysis [4][8] Strategic Partnerships - IBN will utilize its extensive distribution network, which includes over 5,000 syndication outlets and a large social media following, to promote Oncotelic Therapeutics [5][6] - The partnership aims to enhance Oncotelic's visibility among investors, journalists, and the general public, leveraging IBN's experience with over 500 client partners [6][9]

AUSTIN, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The MiningNewsWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The MiningNewsWire Podcast features revealing sit-downs with executives who are shaping the future of the global mining industry. The l ...

Core Insights - The BioMedWire Podcast features an interview with Robert Thast, CEO of Izotropic Corp, focusing on the company's innovative technologies for breast cancer screening and diagnosis [2][3][4] Company Overview - Izotropic Corp is a medical device company that is commercializing the IzoView Breast CT Imaging System, which aims to improve early cancer detection by identifying cancers as small as 2 millimeters, compared to the current standard of care that averages 11 millimeters [3][4] Technology and Innovation - The company has developed unique AI capabilities that are expected to gain acceptance in the market, potentially making Izotropic a target for acquisition by larger firms [5] - Izotropic's intellectual property strategy includes a portfolio of patents and trade secrets to protect its innovations in the imaging space [5] Market Strategy - The commercialization strategy involves a phased rollout of the IzoView system, starting in Europe and then expanding to the U.S., targeting hospitals, medical facilities, and imaging clinics [6] - The combined U.S. and European markets represent nearly 50% of the global market for breast imaging devices [6] Future Outlook - Securing FDA approval is seen as a critical milestone that would open up significant market opportunities for Izotropic [6]

Core Insights - Investors are considering Bancolombia (CIB) and ICICI Bank Limited (IBN) for potential value opportunities in the Banks - Foreign sector [1] Valuation Metrics - Bancolombia (CIB) has a forward P/E ratio of 7.34, while ICICI Bank (IBN) has a forward P/E of 19.81 [5] - CIB's PEG ratio is 1.04, indicating a more favorable valuation compared to IBN's PEG ratio of 1.98 [5] - CIB has a P/B ratio of 2.3, compared to IBN's P/B ratio of 2.79, suggesting CIB is more undervalued relative to its book value [6] Analyst Outlook - CIB currently holds a Zacks Rank of 2 (Buy), indicating a more positive earnings estimate revision activity compared to IBN's Zacks Rank of 3 (Hold) [3][7] - The stronger estimate revision activity for CIB suggests an improving analyst outlook, making it a more attractive option for value investors [3][7] Value Grades - CIB has received a Value grade of A, while IBN has a Value grade of D, highlighting the relative undervaluation of CIB [6]

Core Insights - GlobalTech Corp. has appointed IBN to lead its corporate communications efforts, aiming to enhance its visibility in the market [1][4] - The company focuses on balancing internal innovation with strategic acquisitions to drive growth and long-term value creation [2] - GlobalTech's portfolio includes AI-powered solutions across various sectors, with flagship platforms such as ThrivoAI and Baseball Blitz [2] Company Strategy - GlobalTech is actively pursuing technology-centric acquisitions and forming strategic regional alliances to strengthen its market presence [3] - The partnership with regional players like Omantel is crucial for growth in the Middle East, which is identified as a key market [3] Communication and Outreach - IBN will utilize its extensive distribution network, which includes over 5,000 syndication outlets and a large social media following, to promote GlobalTech [4][5] - IBN's experience with over 500 client partners and a diverse audience positions it well to enhance GlobalTech's outreach to investors and the public [5] Corporate Overview - GlobalTech is committed to growth in AI, big data, and frontier technologies, empowering innovative companies through strategic partnerships and investments [5] - The company aims to drive transformation across global markets by leveraging its diversified portfolio and expertise [5]

Company Overview - SEGG Media Corp. (NASDAQ: SEGG) is a technology company focused on the intersection of sports, entertainment, and gaming, operating under a portfolio that includes Sports.com, Concerts.com, and Lottery.com [2][8] - The company is committed to redefining digital fan engagement and ethical gaming through AI-driven live experiences [8] Leadership Insights - Matthew McGahan, President and CEO of SEGG Media, discussed the company's transformation since his involvement in October 2022, emphasizing a turnaround strategy that has repositioned Lottery.com within a broader tech-driven gaming framework [3][4] - McGahan highlighted an aggressive buy-and-build strategy aimed at expanding the value of SEGG Media's core brands, with a focus on identifying businesses that align with their verticals [5] Future Strategy - The company is poised for significant growth, with McGahan expressing confidence in the execution of their long-term vision and the importance of the next six months for upcoming acquisitions and announcements [6][5] - SEGG Media aims to transition from recovery to high-impact execution, indicating a shift in focus towards operational effectiveness and market expansion [6][5]

Core Insights - ICICI Bank has been fined INR7.5 million ($85,479) by the Reserve Bank of India (RBI) for non-compliance with regulatory requirements [1][7] - The penalty is related to failures in property valuation and the opening of current accounts [3][4] - This fine follows a previous penalty of INR97.8 lakhs imposed in May 2025 for non-compliance with cybersecurity and KYC directives [5][7] Regulatory Compliance Issues - The RBI's inspection revealed that ICICI Bank did not conduct independent property valuations for certain mortgage loans [3] - The bank also opened and maintained current accounts that did not meet regulatory standards [3][4] - The RBI's action is based solely on compliance shortcomings and does not affect the validity of transactions between the bank and its clients [4] Financial Performance Context - Over the past six months, ICICI Bank's shares have increased by 12.2%, while the industry has seen a rise of 22.3% [5] - ICICI Bank currently holds a Zacks Rank of 3 (Hold) [8]